Archived Investigations

Erasca, Inc. (NasdaqGS: ERAS)

Company Name:Erasca, Inc.
Stock Symbol:NasdaqGS: ERAS
Court:Southern District of California
Class Period Start:01/14/2025
Class Period End (inclusive):04/26/2026
Filing Deadline:The deadline has passed.
June 16, 2026

According to the Complaint, Erasca and certain of its executives are charged with failing to disclose material information during the class period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the preclinical data for the Company’s ERAS-0015 product, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors, was based on improper comparisons to Revolution Medicines, Inc. and placed Erasca at risk of violating patent and trade secret protections; and (ii) based on the foregoing, the defendants lacked a reasonable basis for their positive statements related to ERAS-0015.

The case is Cheng v. Erasca, Inc., No. 26-cv-03481.

Click here to read the first filed complaint.